61
Participants
Start Date
September 30, 1997
Primary Completion Date
August 31, 2002
Study Completion Date
January 31, 2003
filgrastim
10 mcg/kg/d, day 2 through last day of leukapheresis
carboplatin
18 AUC IV, approximately days 21, 42
cyclophosphamide
4 gm/m2 IV, day 1
melphalan
140 mg/m2 IV , approximately day 63
paclitaxel
170 mg/m2 IV day 1
bone marrow ablation with stem cell support
peripheral blood stem cell transplantation
Stem Cell Sciences, New York
New York Medical College, Valhalla
University of Rochester School of Medicine, Rochester
University of Pennsylvania Cancer Center, Philadelphia
Temple University Cancer Center, Philadelphia
Bone Marrow Stem Cell Transplant Institute of Florida, Fort Lauderdale
Methodist Hospital-Central Unit, Memphis
Medical College of Wisconsin, Milwaukee
Lutheran General Cancer Care Center, Park Ridge
University of Chicago Cancer Research Center, Chicago
Scripps Clinic, La Jolla
University of California San Diego, La Jolla
Walter Reed Army Medical Center, Washington D.C.
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
National Cancer Institute (NCI)
NIH
UNC Lineberger Comprehensive Cancer Center
OTHER